Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, Marcos, Barbacid, Mariano·2009·Nature Reviews Cancer
DOI 10.1038/nrc2602

Cited by (1,005)

Items 101–200 of 1,005

  1. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review
    Paweł Łukasik, Michał Załuski, Izabela Gutowska · 2021 · International Journal of Molecular Sciences
  2. Ribociclib (LEE011): mechanism of action and clinical impact of this selective cyclin-dependent kinase 4/6 inhibitor in various solid tumors
    Tripathy, Debu, Bardia, Aditya, Sellers, William R. · 2017 · Clinical Cancer Research
  3. Autophagy regulation and its role in cancer
    Séverine Lorin, Ahmed Hamaï, Maryam Mehrpour, Patrice Codogno · 2013 · Seminars in Cancer Biology
  4. Molecular pathways: CDK4 inhibitors for cancer therapy
    Dickson, Mark A. · 2014 · Clinical Cancer Research
  5. Neuronal cell cycle: the neuron itself and its circumstances
    José María Frade, María Carmen Ovejero-Benito · 2015 · Cell Cycle
  6. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
    Alam, Hunain, Tang, Ming, Maitituoheti, Mayinuer, Dhar, Shilpa S., Kumar, Manish, Han, Chae Young, Ambati, Chandrashekar R., Amin, Samir B., Gu, Bingnan, Chen, Tsai-Yu et al. · 2020 · Cancer Cell
  7. CDK1 structures reveal conserved and unique features of the essential cell cycle CDK
    Nicholas R. Brown, Svitlana Korolchuk, Mathew P. Martin, Will A. Stanley, R. Moukhametzianov, Martin E. M. Noble, Jane Endicott · 2015 · Nature Communications
  8. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis
    Jun‐Li Deng, Yunhua Xu, Guo Wang · 2019 · Frontiers in Genetics
  9. Caspase control: protagonists of cancer cell apoptosis.
    Michael V. Fiandalo, Natasha Kyprianou · 2012 · PubMed
  10. Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
    Xueqian Gong, Lacey M. Litchfield, Yue Webster, Li-Chun Chio, Swee Seong Wong, Trent R. Stewart, Michele S. Dowless, Jack Alan Dempsey, Yi Arial Zeng, Raquel Torres et al. · 2017 · Cancer Cell
  11. Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
    Lee, Yoonjin, Dominy, John E., Choi, Yoon Jong, Jurczak, Michael, Tolliday, Nicola, Camporez, Joao Paulo, Chim, Helen, Lim, Ji-Hong, Ruan, Hai-Bin, Yang, Xiaoyong et al. · 2014 · Nature
  12. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
    Wiedemeyer, W. Ruprecht, Dunn, Ian F., Quayle, Steven N., Zhang, Jianhua, Chheda, Milan G., Dunn, Gavin P., Zhuang, Li, Rosenbluh, Joseph, Chen, Shujuan, Xiao, Yonghong et al. · 2010 · Proceedings of the National Academy of Sciences
  13. Towards precision oncology in advanced prostate cancer
    Sheng‐Yu Ku, Martin Edwin Gleave, Himisha Beltran · 2019 · Nature Reviews Urology
  14. Pervasive Protein Thermal Stability Variation during the Cell Cycle
    Isabelle Becher, Amparo Andrés‐Pons, Natalie Romanov, Frank Stein, Maike Schramm, Florence Baudin, Dominic Helm, Nils Kurzawa, André Mateus, Marie‐Therese Mackmull et al. · 2018 · Cell
  15. Killing cells by targeting mitosis
    Eusebio Manchado, María Guillamot, Marcos Malumbres · 2012 · Cell Death and Differentiation
  16. Inhibition of cancer cell invasion and metastasis by genistein
    Janet M. Pavese, Rebecca Farmer, Raymond C. Bergan · 2010 · Cancer and Metastasis Reviews
  17. Regulating DNA Replication in Eukarya
    K. Siddiqui, Kin Fan On, John F.X. Diffley · 2013 · Cold Spring Harbor Perspectives in Biology
  18. Coordinating gene expression during the cell cycle
    Martin Fischer, Amy E. Schade, Timothy B. Branigan, Gerd A. Müller, James A. DeCaprio · 2022 · Trends in Biochemical Sciences
  19. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression
    Hossain, Dewan Md Sakib, Javaid, Sarah, Cai, Mingmei, Zhang, Chunsheng, Sawant, Anandi, Hinton, Marlene, Sathe, Manjiri, Grein, Jeff, Blumenschein, Wendy, Pinheiro, Elaine M. et al. · 2018 · Journal of Clinical Investigation
  20. Cyclin D-CDK4/6 functions in cancer
    Xueliang Gao, Gustavo W. Leone, Haizhen Wang · 2020 · Advances in cancer research
  21. The intersection between DNA damage response and cell death pathways.
    Somaira Nowsheen, Eddy Shih-Hsin Yang · 2012 · PubMed
  22. Piperine inhibits the growth and motility of triple-negative breast cancer cells
    Anna L. Greenshields, Carolyn D. Doucette, Kimberly M. Sutton, Laurence Madera, Henry G. Annan, Paul B. Yaffe, Allison F. Knickle, Zhongmin Dong, David W. Hoskin · 2014 · Cancer Letters
  23. Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells
    Kalaszczynska, Ilona, Geng, Yan, Iino, Tadafumi, Mizuno, Shin-ichi, Choi, Yoon, Kondratiuk, Ilona, Silver, Daniel P., Wolgemuth, Debra J., Akashi, Koichi, Sicinski, Piotr · 2009 · Cell
  24. Hydrogen sulfide in cancer: Friend or foe?
    Dongdong Wu, Weirong Si, Ming-Jie Wang, Shuangyu Lv, Ailing Ji, Yanzhang Li · 2015 · Nitric Oxide
  25. Physiological Relevance of Cell Cycle Kinases
    Marcos Malumbres · 2011 · Physiological Reviews
  26. Calcium signaling and cell cycle: Progression or death
    Juliette F Humeau, José Manuel Bravo‐San Pedro, Ilio Vitale, Lucı́a Núñez, Carlos Villalobos, Guido Kroemer, Laura Senovilla · 2017 · Cell Calcium
  27. Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
    Matthias Schmidt, Alexander Rohe, Charlott Platzer, Abdulkarim Najjar, Frank Erdmann, Wolfgang Sippl · 2017 · Molecules
  28. Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential
    Nicole L. Solimini, Qikai Xu, Craig H. Mermel, Anthony C. T. Liang, Michael R. Schlabach, Ji Luo, Anna E. Burrows, Anthony N. Anselmo, Andrea L. Bredemeyer, Mamie Z. Li et al. · 2012 · Science
  29. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors
    Sunil Kumar Tripathi, Ravikumar Muttineni, Sanjeev Kumar Singh · 2013 · Journal of Theoretical Biology
  30. Autophagy and the Cell Cycle: A Complex Landscape
    Søs Grønbæk Mathiassen, Daniela De Zio, Francesco Cecconi · 2017 · Frontiers in Oncology
  31. Targeting CDK1 in cancer: mechanisms and implications
    Qiushi Wang, Ann M. Bode, Tianshun Zhang · 2023 · npj Precision Oncology
  32. Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma
    Stefano Monti, Bjoern Chapuy, Kunihiko Takeyama, Scott J. Rodig, Yansheng Hao, Kelly T. Yeda, Haig Inguilizian, Craig H. Mermel, Treeve Currie, Ahmet Doǧan et al. · 2012 · Cancer Cell
  33. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.
    Wang, Qian, Ma, Shuai, Song, Nan, Li, Xin, Liu, Ling, Yang, Shangda, Ding, Xiang, Shan, Lin, Zhou, Xing, Su, Dongxue et al. · 2016 · Journal of Clinical Investigation
  34. CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation
    Tigan, A-S, Bellutti, F, Kollmann, K, Tebb, G, Sexl, V · 2016 · Oncogene
  35. Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
    Eusebio Manchado, María Guillamot, Guillermo de Cárcer, Manuel Eguren, Michelle Trickey, Irene García-Higuera, Sergio Moreno, Hiroyuki Yamano, Marta Cañamero, Marcos Malumbres · 2010 · Cancer Cell
  36. DNA damage tolerance: a double-edged sword guarding the genome.
    Gargi Ghosal, Junjie Chen · 2013 · PubMed
  37. Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
    Michela Piezzo, Stefania Cocco, Roberta Caputo, Daniela Cianniello, Germira Di Gioia, Vincenzo Di Lauro, Giuseppina Fusco, Claudia Martinelli, Francesco Nuzzo, Matilde Pensabene et al. · 2020 · International Journal of Molecular Sciences
  38. Fluorescent indicators for simultaneous reporting of all four cell cycle phases
    Bryce T. Bajar, Amy J. Lam, Ryan K. Badiee, Young-Hee Oh, Jun Chu, Xin X. Zhou, Namdoo Kim, Benjamin B. Kim, Mingyu Chung, Arielle L. Yablonovitch et al. · 2016 · Nature Methods
  39. Centrosomes and cancer: revisiting a long-standing relationship
    Pierre Gönczy · 2015 · Nature reviews. Cancer
  40. Targeting the RB-E2F pathway in breast cancer
    Jeff Johnson, Bram Thijssen, Ultan McDermott, Mathew J. Garnett, Lodewyk F.A. Wessels, René Bernards · 2016 · Oncogene
  41. Spatiotemporal dissection of the cell cycle with single-cell proteogenomics
    Diana Mahdessian, Anthony J. Cesnik, Christian Gnann, Frida Danielsson, Lovisa Stenström, Muhammad Arif, Cheng Zhang, Trang H. Le, Fredric Johansson, Rutger Schutten et al. · 2021 · Nature
  42. New Roles of Cyclin D1
    Pestell, Richard G. · 2013 · The American Journal of Pathology
  43. Molecular mechanisms involved in farnesol-induced apoptosis
    Joung Hyuck Joo, Anton M. Jetten · 2009 · Cancer Letters
  44. The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
    Ricardo Titze‐de‐Almeida, Catherine David, Simoneide Souza Titze-de-Almeida · 2017 · Pharmaceutical Research
  45. A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspects
    Farshad Abedi, Bibi Marjan Razavi, Hossein Hosseinzadeh · 2019 · Phytotherapy Research
  46. Cell cycle staging of individual cells by fluorescence microscopy
    Vassilis Roukos, Gianluca Pegoraro, Ty C. Voss, Tom Misteli · 2015 · Nature Protocols
  47. Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
    Raquel Torres-Guzmán, Bruna Calsina, Ana Hermoso, Carmen Baquero, Beatriz Alvarez, Joaquín Amat, Ann M. McNulty, Xueqian Gong, Karsten Boehnke, Jian Du et al. · 2017 · Oncotarget
  48. Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
    Kazuhiro Araki, Yasuo Miyoshi · 2017 · Breast Cancer
  49. Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer Cells
    Daniel Hess, Jeffrey W. Chisholm, R. Ariel Igal · 2010 · PLoS ONE
  50. CDK4: A Key Player in the Cell Cycle, Development, and Cancer
    Suzanne J. Baker, E. Premkumar Reddy · 2012 · Genes & Cancer
  51. Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors
    Lingle Wang, Yuqing Deng, Jennifer L. Knight, Yujie Wu, Byungchan Kim, Woody Sherman, John C. Shelley, Teng Lin, Robert Abel · 2013 · Journal of Chemical Theory and Computation
  52. The role of Candida in intraperitoneal infections.
    Joseph S. Solomkin, Anna B. Flohr, Paul G. Quie, Richard L. Simmons · 1980 · PubMed
  53. Glycogen synthase kinase 3 beta: can it be a target for oral cancer
    Rajakishore Mishra · 2010 · Molecular Cancer
  54. A unified model for the G1/S cell cycle transition
    Samuel Hume, Grigory L. Dianov, Kristijan Ramadan · 2020 · Nucleic Acids Research
  55. Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
    Lessard, Frédéric, Igelmann, Sebastian, Trahan, Christian, Huot, Geneviève, Saint-Germain, Emmanuelle, Mignacca, Lian, Del Toro, Neylen, Lopes-Paciencia, Stéphane, Le Calvé, Benjamin, Montero, Marinieve et al. · 2018 · Nature Cell Biology
  56. Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
    Tahir Ali Chohan, Hai‐Yan Qian, Youlu Pan, Jian‐Zhong Chen · 2014 · Current Medicinal Chemistry
  57. The role of CDK6 in cancer
    Sofie Nebenfuehr, Karoline Kollmann, Veronika Sexl · 2020 · International Journal of Cancer
  58. DDX3 Regulates Cell Growth through Translational Control of Cyclin E1
    Ming‐Chih Lai, Wen‐Cheng Chang, Sheau-Yann Shieh, Woan‐Yuh Tarn · 2010 · Molecular and Cellular Biology
  59. Targeting the cell cycle in breast cancer: towards the next phase
    Kelsie L. Thu, Isabel Soria‐Bretones, Tak W. Mak, DW Cescon · 2018 · Cell Cycle
  60. Cell cycle regulation of DNA double-strand break end resection by Cdk1-dependent Dna2 phosphorylation
    Xuefeng Chen, Hengyao Niu, Woo-Hyun Chung, Zhu Zhu, Alma Papusha, Eun Yong Shim, Sang Eun Lee, Patrick Sung, Grzegorz Ira · 2011 · Nature Structural & Molecular Biology
  61. Negative Regulation of Vps34 by Cdk Mediated Phosphorylation
    Tsuyoshi Furuya, Minsu Kim, Marta M. Lipinski, Juying Li, Dohoon Kim, Tao Lu, Yong Shen, Lucia E. Rameh, Bruce A. Yankner, Li‐Huei Tsai et al. · 2010 · Molecular Cell
  62. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
    Mathew Craig Casimiro, Marco Antonio Velasco-Velázquez, Charmina Aguirre-Alvarado, Richard G. Pestell · 2014 · Expert Opinion on Investigational Drugs
  63. The MYCN Protein in Health and Disease
    María Victoria Ruiz-Pérez, Aine Brigette Henley, Marie Arsenian‐Henriksson · 2017 · Genes
  64. Mammalian cell cycle cyclins
    Diego Martínez‐Alonso, Marcos Malumbres · 2020 · Seminars in Cell and Developmental Biology
  65. The Transcription Factor FOXM1 (Forkhead box M1)
    Inken Wierstra · 2013 · Advances in cancer research
  66. Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
    Qian Wang, Jessamy C. Tiffen, Charles G. Bailey, Melanie Lehman, William Ritchie, Ladan Fazli, Cynthia Metierre, Yue Feng, Estelle Li, Martin Edwin Gleave et al. · 2013 · JNCI Journal of the National Cancer Institute
  67. Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
    Marc Thill, Marcus Schmidt · 2018 · Therapeutic Advances in Medical Oncology
  68. Cellular senescence and the tumour microenvironment
    Masaki Takasugi, Yuya Yoshida, Naoko Ohtani · 2022 · Molecular Oncology
  69. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
    Kaixuan Zeng, Weihao Li, Yue Wang, Zifei Zhang, Linjie Zhang, Weili Zhang, Yue Xing, Chi Zhou · 2023 · Advanced Science
  70. CRL4AMBRA1 is a master regulator of D-type cyclins
    Daniele Simoneschi, Gergely Róna, Nan Zhou, Yeon‐Tae Jeong, Shaowen Jiang, Giacomo Milletti, Arnaldo Arbini, Alfie O’sullivan, Andrew A. Wang, Sorasicha Nithikasem et al. · 2021 · Nature
  71. Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
    Xiaoqi Liu · 2015 · Translational Oncology
  72. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies
    Natalia Bailón-Moscoso, Gabriela Cevallos-Solorzano, Juan Carlos Romero-Benavides, María Isabel Ramírez-Orellana · 2017 · Current Genomics
  73. Cell-cycle Checkpoints and Aneuploidy on the Path to Cancer
    Elizabeth Wenzel, Amareshwar T.K. Singh · 2018 · In Vivo
  74. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D
    Andrea C. Chaikovsky, Chuan Li, Edwin E. Jeng, Samuel Loebell, Myung Chang Lee, Christopher W. Murray, Ran Cheng, János Demeter, Danielle L. Swaney, Sihan Chen et al. · 2021 · Nature
  75. Recent advances of highly selective CDK4/6 inhibitors in breast cancer
    Xu, Hanxiao, Yu, Shengnan, Liu, Qian, Yuan, Xun, Mani, Sridhar, Pestell, Richard G., Wu, Kongming · 2017 · Journal of Hematology & Oncology
  76. Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway
    Shan Zhu, Wenhui Jiao, Yanglu Xu, Lanjiao Hou, Hui Li, Jingrong Shao, Xiaoliang Zhang, Ran Wang, Dexin Kong · 2021 · Life Sciences
  77. Circadian Clock, Cell Division, and Cancer: From Molecules to Organism
    Anton Shostak · 2017 · International Journal of Molecular Sciences
  78. Mechanisms, Hallmarks, and Implications of Stem Cell Quiescence
    Inchul Cho, Prudence PokWai Lui, Jana Obajdin, Federica Riccio, Wladislaw Stroukov, Thea L. Willis, Francesca M. Spagnoli, Fiona M. Watt · 2019 · Stem Cell Reports
  79. Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors
    Nawal Bendris, Bénédicte Lemmers, Jean Marie Blanchard · 2015 · Cell Cycle
  80. The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
    Gernot Polier, Jennifer Neumann, Frédéric Thuaud, Nigel Ribeiro, Christoph Gelhaus, Hendrik Schmidt, Marco Giaisi, Rebecca Köhler, Wolfgang W. Müller, Peter Proksch et al. · 2012 · Chemistry & Biology
  81. Targeting CDK6 in cancer: State of the art and new insights
    Solomon Tadesse, Mingfeng Yu, Malika Kumarasiri, Bich Thuy Le, Shudong Wang · 2015 · Cell Cycle
  82. Chronotherapy and the molecular clock: Clinical implications in oncology☆
    Pasquale F. Innominato, Françis Lévi, Georg A. Bjarnason · 2010 · Advanced Drug Delivery Reviews
  83. Roles of pH in control of cell proliferation
    Mette Flinck, Signe Hoejland Kramer, Stine F. Pedersen · 2018 · Acta Physiologica
  84. miRNA dysregulation is an emerging modulator of genomic instability
    Ana P. Ferragut Cardoso, Mayukh Banerjee, Alexandra N. Nail, Angeliki Lykoudi, J. Christopher States · 2021 · Seminars in Cancer Biology
  85. Cyclin C is a haploinsufficient tumour suppressor
    Na Li, Anne Fassl, Joel M. Chick, Hiroyuki Inuzuka, Xiaoyu Li, Marc R. Mansour, Lijun Liu, Haizhen Wang, Bryan King, Shavali Shaik et al. · 2014 · Nature Cell Biology
  86. Activated oncogenic pathways and therapeutic targets in extranodal nasal‐type NK/T cell lymphoma revealed by gene expression profiling
    Siok‐Bian Ng, Viknesvaran Selvarajan, Gaofeng Huang, Jianbiao Zhou, Andrew L. Feldman, Mark Law, Yok‐Lam Kwong, Norio Shimizu, Yoshitoyo Kagami, Katsuyuki Aozasa et al. · 2010 · The Journal of Pathology
  87. Recent treatment progress of triple negative breast cancer
    Changqing Yang, Jie Liu, Shi‐Qi Zhao, Zhu Kun, Gong Zi-Qian, Ran Xu, Hui‐Meng Lu, Ren‐Bin Zhou, Gang Zhao, Da‐Chuan Yin et al. · 2019 · Progress in Biophysics and Molecular Biology
  88. BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application
    Gerhard Siemeister, Ulrich Lücking, Antje Margret Wengner, Philip Lienau, Wolfram Steinke, Christoph A. Schatz, Dominik Mumberg, Karl B. Ziegelbauer · 2012 · Molecular Cancer Therapeutics
  89. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
    R. Ariel Igal · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  90. Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
    Xiaodong Huang, Matthew K. Summers, Victoria C. Pham, Jennie Rebecca Lill, Jinfeng Liu, Gwanghee Lee, Donald S. Kirkpatrick, Peter K. Jackson, G. Fang, Vishva M. Dixit · 2011 · Molecular Cell
  91. Structural and functional analysis of the Cdk13/Cyclin K complex
    Greifenberg, Ann Katrin, Hönig, Dana, Pilarova, Kveta, Düster, Robert, Bartholomeeusen, Koen, Bösken, Christian A., Anand, Kanchan, Blazek, Dalibor, Geyer, Matthias · 2016 · Cell Reports
  92. Absolute Proteome and Phosphoproteome Dynamics during the Cell Cycle of Schizosaccharomyces pombe (Fission Yeast)
    Alejandro Carpy, Karsten Krug, Sabine Graf, André Koch, Sasa Popic, Silke Hauf, Boris Maček · 2014 · Molecular & Cellular Proteomics
  93. Cross-talk between the circadian clock and the cell cycle in cancer
    Matúš Soták, Alena Sumová, Jiřı́ Pácha · 2014 · Annals of Medicine
  94. Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
    Prithviraj Bose, Gary Lee Simmons, Steven Grant · 2013 · Expert Opinion on Investigational Drugs
  95. Retinoids and rexinoids in cancer prevention: from laboratory to clinic
    Iván P. Uray, Ethan Dmitrovsky, Powel H. Brown · 2015 · Seminars in Oncology
  96. β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects
    Haoyu Wang, Zhi Wang, Zihui Zhang, Jingchun Liu, Hong Li · 2023 · Advances in Nutrition
  97. Liver Failure After Extended Hepatectomy in Mice Is Mediated by a p21-Dependent Barrier to Liver Regeneration
    Lehmann, Kuno, Tschuor, Christoph, Rickenbacher, Andreas, Jang, Jae–Hwi, Oberkofler, Christian E., Tschopp, Oliver, Schultze, Simon M., Raptis, Dimitri A., Weber, Achim, Graf, Rolf et al. · 2012 · Gastroenterology
  98. Stellettin B Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K/Akt/mTOR Pathway
    Ran Wang, Qian Zhang, Xin Peng, Chang Zhou, Yuxu Zhong, Xi Chen, Yuling Qiu, Meihua Jin, Min Gong, Dexin Kong · 2016 · Scientific Reports
  99. Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention
    Joanna Xuan Hui Goh, Loh Teng‐Hern Tan, Joo Kheng Goh, Kok‐Gan Chan, Priyia Pusparajah, Learn−Han Lee, Bey Hing Goh · 2019 · Cancers
  100. CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents
    Abel Tesfaye Anshabo, Robert W. Milne, Shudong Wang, Hugo Albrecht · 2021 · Frontiers in Oncology